Organisation · Unternehmen
GSK
gsk-eutr-32292577
Aussagen (8)
eu transparency category
Companies & groups
dokumentiert
[Q-21677]
eu transparency goals
GSK is a global biopharmaceutical company with the purpose to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding people can thrive. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology. Our scale and strong R&D and manufacturing footprint in the EU give us a unique opportunity to make a positive impact on the lives of people in the region.
dokumentiert
[Q-21677]
eu transparency id
7990322925-77
dokumentiert
[Q-7535]
headquarters city
London
dokumentiert
[Q-21677]
headquarters country
GB
dokumentiert
[Q-21677]
interest class
business_company
dokumentiert
[Q-29773]
legal form
Corporation
dokumentiert
[Q-21677]
legal form class
ausland_sonstig
berichtet
[Q-29773]